High expression of MYO10 contributes to the tumor invasion and migration of breast cancer (Cao et al. 2014), prostate cancer (Makowska et al. 2015), and colorectal cancer (Ou et al. 2022). The gene discussed is MYO10; the disease is prostate cancer.